Aquestive Therapeutics, Inc.
AQSTNASDAQHealthcare● Active
$3.91
$-0.02(-0.51%)
Market Cap$388288947
P/E Ratio—
52W High$7.55
52W Low$2.93
Aquestive Therapeutics, Inc. (AQST) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AQST · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $121.17M | $71.55M | $23.87M | $27.27M | $28.02M |
| Net Receivables | $17.76M | $7.34M | $8.47M | $4.70M | $12.12M |
| Inventory | $6.17M | $6.04M | $6.77M | $5.78M | $4.04M |
| Total Current Assets | $149.27M | $88.22M | $40.97M | $39.89M | $47.26M |
| PP&E Net | $8.51M | $8.98M | $9.74M | $9.30M | $7.78M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $1.28M | $1.44M | $0.05M |
| Total Assets | $160.43M | $101.42M | $57.42M | $57.07M | $61.99M |
| Liabilities | |||||
| Short-Term Debt | $11.63M | $0.03M | $0.02M | $18.70M | $2.02M |
| Accounts Payable | $29.86M | $10.29M | $8.93M | $9.95M | $8.31M |
| Total Current Liabilities | $47.61M | $18.86M | $18.31M | $39.53M | $21.96M |
| Long-Term Debt | $115.48M | $32.50M | $27.51M | $33.45M | $51.55M |
| Total Liabilities | $194.09M | $161.58M | $163.91M | $175.62M | $144.13M |
| Stockholders Equity | |||||
| Retained Earnings | ($447.00M) | ($363.21M) | ($319.08M) | ($311.21M) | ($256.80M) |
| Total Stockholders Equity | ($33.66M) | ($60.16M) | ($106.49M) | ($118.55M) | ($82.13M) |
| Total Liab & Equity(computed) | $160.43M | $101.42M | $57.42M | $57.07M | $61.99M |
| Debt Summary | |||||
| Total Debt | $131.44M | $38.00M | $33.32M | $57.49M | $56.42M |
| Net Debt | $10.28M | ($33.54M) | $9.45M | $30.21M | $28.40M |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Aquestive Therapeutics, Inc. data
About Aquestive Therapeutics, Inc. (AQST) Balance Sheet
Aquestive Therapeutics, Inc. (AQST) balance sheet shows total assets of $0.16B with cash of $0.12B. Total liabilities are $0.19B, total debt $0.13B, and stockholders equity ($0.03B).
Frequently asked questions
AQST · 4 questionsAquestive Therapeutics, Inc. has total debt of $0.13B with net debt of $0.01B.
AQST total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10